MedPath

Comparing The Performance Of Two Different Daily Disposable Lenses (MIKI)

Not Applicable
Completed
Conditions
Myopia
Interventions
Device: Test Contact Lens
Device: Control Contact Lens
Registration Number
NCT04492397
Lead Sponsor
Coopervision, Inc.
Brief Summary

The objective of the study is to evaluate and compare the performance of study test lens to study control lens, when worn on a daily disposable modality over a period of approximately one week each

Detailed Description

The study is a prospective, double masked (investigator and participant), bilateral, randomized,one week cross-over dispensing study, which evaluates the study test lens and control lens.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria
  1. Is at least 17 years of age and has full legal capacity to volunteer;
  2. Has read and signed an information consent letter;
  3. Is willing and able to follow instructions and maintain the appointment schedule;
  4. Habitually wears soft contact lenses in daily wear, for minimum of 6-months;
  5. Is correctable to a visual acuity of 20/40 or better (in each eye) with the study lenses;
  6. Has an astigmatism of ≤ 1.00 D in subjective refraction;
  7. Can be fit with study contact lenses with a power between -2.00 and -5.00 DS;
  8. Demonstrates an acceptable fit with the study lenses;
  9. Habitually wears single vision soft contact lenses for at least 8 hours per day, 5 days a week, and is willing to wear contact lenses for at least 12 hours a day in the study.
Exclusion Criteria
  1. Is participating in any concurrent clinical or research study;
  2. Has any known active* ocular disease and/or infection;
  3. Has a systemic condition that in the opinion of the investigator may affect a study outcome variable;
  4. Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable;
  5. Has known sensitivity to the diagnostic pharmaceuticals to be used in the study;
  6. Is pregnant, lactating or planning a pregnancy at the time of enrolment because the associated hormonal changes cause changes in the tear layer which impact contact lens comfort. Verbal confirmation at the screening visit is sufficient;
  7. Is aphakic;
  8. Has undergone refractive error surgery;
  9. Is an employee of the Centre for Ocular Research & Education;
  10. Has participated in the BOXER (i.e. EX-MKTG-107, phases 1 or 2) or BASSET (EXMKTG-113) Study;
  11. Has participated in any clinical trials within a week prior to the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Control Contact LensControl Contact LensSubjects will be randomized to wear control lenses for one week and then switch to test lenses for one week.
Control Contact LensTest Contact LensSubjects will be randomized to wear control lenses for one week and then switch to test lenses for one week.
Test Contact lensTest Contact LensSubjects will be randomized to wear test lenses for one week and then switch to control lenses for one week.
Test Contact lensControl Contact LensSubjects will be randomized to wear test lenses for one week and then switch to control lenses for one week.
Primary Outcome Measures
NameTimeMethod
Overall Lens Fit Acceptance1 week

Overall fit acceptance (0-4, 0.50 steps) (0 - lens should not be worn at all,1 - Borderline but unacceptable, 2 - Minimally acceptable, 3 - Not perfect but OK to dispense, 4 - Perfect)

Secondary Outcome Measures
NameTimeMethod
Lens Centration1 week

Lens Centration was measured on a scale (0-3) (0 = "Optimally centered", 1 = "Slightly decentered", 2 = Moderate decentration but not encroaching limbus, 3 = "Excessive \& occasionally encroaching limbus")

Post-blink Movement1 week

Post-blink lens movement was measured using an eyepiece reticule while viewing the contact lens in-vivo at 8x magnification in primary gaze, in 0.1mm steps

Push-up Tightness1 week

Push-up tightness in primary gaze measured on a scale (0-100, 5% steps) (0% = falls from cornea without lid support, 50% = optimum and 100% = no movement)

Trial Locations

Locations (1)

University of Waterloo

🇨🇦

Waterloo, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath